Core Scientific, Inc. (NASDAQ:CORZ) has garnered attention as one of the top mid-cap AI stocks, reflecting a shift in investor sentiment and strategic direction within the company. Recent evaluations by two prominent analysts underscore a bullish outlook for Core Scientific, particularly as the landscape of cryptocurrency and artificial intelligence evolves.
On June 3, Bernstein analyst Gautam Chhugani raised the price target for Core Scientific from $24 to $32, maintaining an Outperform rating. This adjustment marks a significant departure from the firm’s earlier valuation focus, which heavily leaned on the company’s Bitcoin mining operations. Bernstein’s newfound emphasis on Core Scientific’s AI infrastructure business signals recognition of the growing importance and potential profitability of this sector, especially as the sentiment related to cryptocurrency faces challenges.
Adding to the positive momentum, Nick Giles of B. Riley similarly adjusted his price target for Core Scientific on May 27, lifting it from $30 to $33. Giles highlighted the company’s remarkable ability to secure contracts from hyperscalers, which reflects the rising demand for its AI capabilities. This revision was informed by recent contractual developments as well as the company’s quarterly performance, further solidifying Core Scientific’s position in the mid-cap AI market.
Core Scientific operates a dual-faceted business model that incorporates digital Bitcoin mining along with high-performance computing infrastructure. The company utilizes its own fleet of miners to generate Bitcoin while also offering hosting services to a range of clients at its U.S.-based operational data centers. This innovative approach places Core Scientific at the intersection of cryptocurrency and AI, enhancing its appeal to investors.
Despite the optimism surrounding Core Scientific, some analysts caution against complacency, suggesting that while the stock holds promise, there are other AI stocks in the market that may present higher upside potential with lower associated risks. Investors seeking undervalued opportunities, coupled with advantages from policies like Trump-era tariffs and the trend towards onshoring, may want to explore further analysis on alternative stocks within the AI space.
As professional analysts continue to spotlight Core Scientific among the best mid-cap investments, the evolving dynamics of its operational focus could set the stage for substantial growth and renewed investor interest.
